Risk factor analysis for bone marrow histiocytic hyperplasia with hemophagocytosis: An autopsy study

Virchows Archiv

Volumn 465, Issue 1, 2014, Pages 109-118

  Inai, Kunihiro ^a   Noriki, Sakon ^a   Iwasaki, Hiromichi ^a   Naiki, Hironobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Bone marrow; Hematological diseases; Histiocytic hyperplasia with hemophagocytosis; Inflammation; Inflammatory cytokine; Sepsis

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BONE MARROW CELL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTIC HYPERPLASIA WITH HEMOPHAGOCYTOSIS; HUMAN; INFANT; LEUKOCYTE COUNT; LEUKOPENIA; MACROPHAGE; MALE; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BONE MARROW; CHILD; CHILD, PRESCHOOL; CYTOKINES; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEMATOLOGIC DISEASES; HISTIOCYTES; HUMANS; HYPERPLASIA; INFANT; INTERLEUKIN-6; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGES; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEPSIS;

EID: 84904745285     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1592-8     Document Type: Article

References (31)

1. Kumar V, Abbas AK, Fausto N, Aster JC (2008) Pathologic bases of disease, 8th edn. Saunders, Philadelphia
2. Suster S, Hilsenbeck S, Rywlin AM (1988) Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations. Hum Pathol 19:705-712
3. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C (2007) Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7:814-822 (Pubitemid 350152044)
4. Janka GE (2007) Hemophagocytic syndromes. Blood Rev 21:245-253
5. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89:4100-4103 (Pubitemid 27220957)
6. Tang YM, Xu XJ (2011) Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment. ScientificWorldJournal 11:697-708
7. Szyper-Kravitz M (2009) The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. Isr Med Assoc J 11:633-634
8. Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG (2004) Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients-a postmortem clinicopathologic analysis. Crit CareMed 32:1316-1321 (Pubitemid 38738586)
9. Hot A, Jaisson I, Girard C, French M, Durand DV, Rousset H, Ninet J (2009) Yield of bone marrow examination in diagnosing the source of fever of unknown origin. Arch Intern Med 169:2018-2023
10. Milner JD,Orekov T,Ward JM, Cheng L, Torres-Velez F, Junttila I, Sun G, Buller M, Morris SC, Finkelman FD, Paul WE (2010) Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood 116:2476-2483
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (1992). Crit Care Med 20:864-874.
12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, Sccm/Esicm/Accp/Ats/Sis, (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256
13. Kaneko T,Wada H (2011) Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. J Clin Exp Hematopathol 51:67-76
14. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T (2008) Regulation of alternative macrophage activation by galectin-3. J Immunol 180:2650-2658
15. Inai K, Iwasaki H, Noriki S, Ikegaya S, Yamashita M, Imamura Y, Takimoto N, Kato H, Ueda T, Naiki H (2007) Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies. Int J Hematol 86:225-232 (Pubitemid 350085811)
16. Inai K, Noriki S, Iwasaki H (2014) Should prophylactic thrombolysis be routine in clinical practice? Evidence from an autopsy case of septicemia. BMC Clin Pathol 14:6
17. Tai K, Iwasaki H, Ikegaya S, Ueda T (2013) Minocycline modulates cytokine and chemokine production in lipopolysaccharide-stimulated THP-1 monocytic cells by inhibiting IkappaB kinase alpha/beta phosphorylation. Transl Res 161:99-109
18. Holm S (1979) A simple sequentially rejective multiple test procedure. Scan J Stat 6:65-70
19. Tang Y, Xu X, Song H, Yang S, Shi S,Wei J, Pan B, Zhao F, Liao C, Luo C (2008) Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome. Br J Haematol 143:84-91
20. Levy L, Nasereddin A, Rav-Acha M, Kedmi M, Rund D, Gatt ME (2009) Prolonged fever, hepatosplenomegaly, and pancytopenia in a 46-year-old woman. PLoS Med 6:e1000053
21. Wong KF, Chan JK (1992) Reactive hemophagocytic syndrome - a clinicopathologic study of 40 patients in an Oriental population. Am J Med 93:177-180
22. Emmenegger U, Reimers A, Frey U, Fux C, Bihl F, Semela D, Cottagnoud P, Cerny A, Spaeth PJ, Neftel KA (2002) Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 132:230-236 (Pubitemid 34733673)
23. Pagano L, Caira M, Valentini CG, Posteraro B, Fianchi L (2010) Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Blood Rev 24:51-61
24. Munford RS, Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316-321 (Pubitemid 32158505)
25. Reichelt U, Jung R, Nierhaus A, Tsokos M (2005) Serial monitoring of interleukin-1beta, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death: a comparative evaluation of potential postmortem markers of sepsis. Int J Legal Med 119:80-87 (Pubitemid 40386254)
26. Tsokos M, Reichelt U, Jung R, Nierhaus A, Puschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci Int 119:47-56 (Pubitemid 32448153)
27. Xing L, Remick DG (2004) Neutrophils as firemen, production of anti-inflammatory mediators by neutrophils in a mixed cell environment. Cell Immunol 231:126-132 (Pubitemid 40775611)
28. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT (2007) Cytokine profiles asmarkers of disease severity in sepsis: amultiplex analysis. Crit Care 11:R49
29. Gomez-Jimenez J, MartinMC, Sauri R, Segura RM, Esteban F, Ruiz JC, Nuvials X, Boveda JL, Peracaula R, Salgado A (1995) Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 171:472-475
30. Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735-6741
31. Schwabe M, Hartert AM, Bertz H, Finke J (2004) Interleukin-8, neutropenia, and graft failure in human stem cell transplantation. Transplantation 78:1086-1088 (Pubitemid 39391876)